PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Qiangji Recipe (containing N. incisium) was used as an adjunctive treatment in a four-week study [PMID:25790672]
Notopterol significantly alleviated pain, gait abnormalities, and attenuated cartilage degradation in mice [PMID:40020461]; Isoimperatorin reduced synovial inflammation in rats [PMID:41053923]
Root extract (NRE) rescued cognitive deficits and attenuated amyloid-beta, tau, and neuroinflammation pathology in APP/PS1 mice [PMID:31783135, PMID:39094757]
Water extract reduced cold allodynia by regulating TRPA1 in mice [PMID:36587876]
Notopterol improved exercise capacity and alleviated cardiac dysfunction by suppressing P2X7R and pyroptosis signals [PMID:36986461]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 39064831 (2024) — Phytochemistry and Biological Profile of the Chinese Endemic Herb Genus Notopterygium. · Molecules (Basel, Switzerland)
- 2.PMID: 39094757 (2024) — Notopterygium incisum roots extract (NRE) alleviates neuroinflammation pathology in Alzheimer's disease through TLR4-NF-κB pathway. · Journal of ethnopharmacology
- 3.PMID: 40020461 (2025) — Notopterol mitigates osteoarthritis progression and relieves pain in mice by inhibiting PI3K/Akt/GPX4-mediated ferroptosis. · International immunopharmacology
- 4.PMID: 2285981 (1990) — Isolation of two new coumarin glycosides from Notopterygium forbesii and evaluation of a Chinese crude drug, qiang-huo, the underground parts of N. incisum and N. forbesii, by high-performance liquid chromatography. · Chemical & pharmaceutical bulletin
- 5.PMID: 41053923